Patents
Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723)
04/2008
04/02/2008EP1904091A2 Compositions and methods for suppressing axonal growth inhibition
03/2008
03/27/2008WO2008034575A1 Iminosugar glycoconjugates
03/27/2008WO2003075845A3 Immunogenicity of glucan binding protein
03/27/2008US20080076904 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/27/2008US20080076188 Luminescent compounds
03/27/2008US20080076166 Method For Producing Polyunsaturated Fatty Acids In Transgenic Organisms
03/27/2008US20080076157 Expression vector comprising nucleotide sequences coding signal sequences for transport of heterologous protein to cytoplasm of microorganism; improving exogenous gene expression
03/27/2008US20080075736 Materials and methods for respiratory disease control in canines
03/27/2008US20080075725 Novel Immunointeractive Molecules and uses Thereof
03/26/2008EP1901761A2 Thrombospondin-1 derived peptides and treatment methods
03/25/2008US7348399 Nanofabricated polypeptide multilayer films, coatings, and microcapsules
03/25/2008US7348319 amination of imidate bounded to (bio)polymer, aminoacid, or drug; reactions avoid direct contact with nitric oxide; substrate is medical device: stent, catheter, wound dressing, prosthesis, implant; restenosis, hypotensive agent, and impotency
03/19/2008EP1575991A4 Peptides comprising aromatic d-amino acids and methods of use
03/19/2008CN101143890A New born calf brain active peptide, preparation method and application thereof in preparing anti-cancer medicament
03/13/2008WO2008028251A1 Dna-binding protein, nucleoprotein complex and method of use
03/13/2008US20080066201 Nucleic acid molecules and other molecules associated with plants
03/13/2008US20080066199 Using expressed sequence tags as gene targeting tool in transformation and generation of transgenic crop plants
03/12/2008EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor
03/12/2008EP1896047A1 Anti-gfralpha3 antibodies
03/11/2008US7341710 Method of identifying molecules that home to a selected organ in vivo
02/2008
02/28/2008WO2008024374A2 Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake
02/28/2008US20080051556 Novel PTP-20, PCP-2, BDP1, CLK, and SIRP proteins and related products and methods
02/28/2008US20080051317 Polypeptides comprising unnatural amino acids, methods for their production and uses therefor
02/28/2008US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture
02/28/2008US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection
02/28/2008US20080050370 Stabilized polypeptide compositions
02/27/2008CN101130569A Production process of flax protein
02/21/2008WO2007120463A3 Compositions and methods for modulation of nek2 kinase activity
02/21/2008US20080045457 Ancestral Hepatitis C virus envelope protein sequence
02/21/2008US20080044857 Methods For Making And Using Mass Tag Standards For Quantitative Proteomics
02/21/2008US20080044854 Site-specific incorporation of amino acids into molecules
02/21/2008US20080044825 Method for Modulating the Evolution of a Polypeptide Encoded by a Nucleic Acid Sequence
02/21/2008US20080044484 Use of polymeric nanoparticles for vaccine delivery
02/20/2008EP1888111A1 Modulation of cholesteryl ester transfer protein (cetp) activity
02/20/2008CN100369922C Methamidophos half-antigen, artificial antigen and its preparing method
02/19/2008US7332571 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
02/19/2008CA2245675C Engineering affinity ligands for macromolecules
02/14/2008US20080039413 Novel compositions and methods in cancer
02/14/2008US20080039393 Metal-binding therapeutic peptides
02/14/2008US20080038365 TRPC6 involved in glomerulonephritis
02/14/2008US20080038349 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase
02/14/2008US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1
02/14/2008US20080038284 Human Immunodeficiency Virus Vaccine
02/14/2008US20080038258 Polypeptides with Reduced Susceptibility to Oxidation and Methods of Making
02/14/2008US20080038199 Methods Related to the Treatment of Neurodegenerative and Inflammatory Conditions
02/13/2008CN101121744A Extraction method for dephenolize cotton seed protein
02/07/2008WO2007113683A3 Modulation of tc10 function and method of treating glucose metabolic disorders
02/07/2008US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof
02/07/2008US20080032919 BMP-7 Variant Compositions, Methods and Uses
02/07/2008US20080032917 Flavivirus protease substrates and inhibitors
02/07/2008US20080032312 Compositions and methods for measuring analyte concentrations
02/07/2008DE102006036285A1 Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms Fractions of whey permeate and their use for the prevention and treatment of type 2 diabetes and the metabolic syndrome
01/2008
01/31/2008WO2008014054A2 Bmp-7 variant compositions, methods and uses
01/31/2008WO2007056511A3 Metal-binding therapeutic peptides
01/31/2008US20080027211 Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments
01/31/2008US20080026421 Transgenic cells comprising peroxisomal membrane polypeptide (PMP) for transport of intracellular proteins to ouside of cell
01/31/2008US20080026017 Novel Dipeptides incorporating selenoamino acids with enhanced bioavailability- Synthesis, pharmaceutical and cosmeceutical applications thereof
01/31/2008US20080025950 Modified Macromolescules and Associated Methods of Synthesis and Use
01/31/2008DE102006035577A1 Röntgendichtes Konjugat Radiopaque conjugate
01/30/2008EP1507804B1 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
01/29/2008US7323179 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
01/29/2008CA2253587C Microplate thermal shift assay and apparatus for ligand development and multi-variable protein chemistry optimization
01/24/2008WO2008011335A2 Metal binding compounds, metal binding compositions, and their uses
01/24/2008US20080021198 Modulators of protein phosphatase 2A and PP2A methyl esterase
01/24/2008US20080021195 Accelerating an exchange reaction between a nucleotide sequence at specific site of a double stranded DNA or RNA; nucleotide chain can be exchanged at a lower temperature and/or at a higher rate
01/24/2008US20080020440 Method of sequestering and/or purifying a polypeptide
01/24/2008US20080020404 Search for cancer markers by a novel screening method
01/22/2008US7321022 Electrostatic layer-by-layer self assembly; exposing film to an oxidizing or reducing agent; alternating layers of oppositely charged polypeptides; 1st layer polypeptide contains sulfhydryl-containing amino acid; 2nd layer polypeptide has two amino acid sequences joined by a glycine a proline linker.
01/17/2008WO2006105490A3 Compositions and methods for treating diseases associated with phlpp
01/17/2008US20080015138 Metal binding compounds, metal binding compositions, and their uses
01/17/2008US20080015137 Methods and Compositions for Targeting Macromolecules Into the Nucleus
01/17/2008US20080014646 Method of presuming domain linker region of protein
01/17/2008US20080014186 Hla-A24 or Hla-A2 Binding Peptides of Parathyroid Hormone-Related Protein
01/15/2008US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents
01/15/2008CA2301854C Protein composition and process for isolating a protein composition from a muscle source
01/10/2008WO2007121147A3 Disheveled pdz modulators
01/10/2008US20080010699 Lysophosphatidic acid acetyltransferases
01/10/2008US20080009444 Biologically active complex of NR6 and cardiotrophin-like-cytokine
01/10/2008US20080009434 at least one aromatic amino acid (phenylalanine); hollow and fibrillar peptide; macroscopic and microscopic articles; self-assembled; 9-fluorenylmethyloxycarbonyl (Fmoc) and benzyloxycarbonyl (Cbz); slow release of drug, nucleic acid molecule or a polypeptide; antibody
01/09/2008EP1876184A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta
01/09/2008EP1874797A1 Method of preparing grafted polylysine dendrimers
01/09/2008EP1460084B1 Novel peptide sy
01/08/2008US7317129 Chemical synthesis of reagents for peptide coupling
01/08/2008US7317087 Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof
01/08/2008US7316905 Method for measurement of hepatitis C virus
01/03/2008WO2007089618A3 Hepatitis c serine protease inhibitors and uses therefor
01/03/2008WO2006107982A3 Methods and precipitating reagents for isolating proteins from proteinaceous material
01/03/2008US20080004427 Methods for arbitrary peptide synthesis
01/03/2008US20080003570 Translation enhancer elements of genes encoding human Tau protein and human alpha-synuclein protein
01/03/2008US20080003200 Tissue selective binding for prostate and/or bone cancer, or adipose tissue; apoptosis induction; diagnosis, prognosis; staging metastatic cancer
01/01/2008US7314929 Organoselenium compounds for cancer chemoprevention
01/01/2008US7314910 In situ diagnosis, detection of antibodies, immunogenic formulations
01/01/2008US7314866 designing a peptide or chemical to mimic the Bax-suppressing function of VPMLKE, VPMLK, PMLKE or PMLK; apoptosis resistance
01/01/2008US7314862 Antitumor agent
12/2007
12/27/2007WO2007149490A1 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins
12/27/2007US20070298123 Anti-angiogenic compositions and methods of use
12/27/2007CA2655929A1 Processes for recovering stabilized formulations of trimers of retroviral envelope (env) proteins
12/26/2007CN101092447A Fibrin enzymolysis auxiliary agent from stalk stuff of plant
12/20/2007US20070293657 Complexes and methods of forming complexes of ribonucleic acids and peptides
12/20/2007US20070293655 Supercritical fluids processing: preparation of protein microparticles and their stabilisation
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 48